JP2014509600A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2014509600A5 JP2014509600A5 JP2013558409A JP2013558409A JP2014509600A5 JP 2014509600 A5 JP2014509600 A5 JP 2014509600A5 JP 2013558409 A JP2013558409 A JP 2013558409A JP 2013558409 A JP2013558409 A JP 2013558409A JP 2014509600 A5 JP2014509600 A5 JP 2014509600A5
- Authority
- JP
- Japan
- Prior art keywords
- alkyl
- group
- carbocycle
- groups
- substituted
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 229910052717 sulfur Inorganic materials 0.000 claims description 39
- 125000003118 aryl group Chemical group 0.000 claims description 34
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 claims description 32
- 229910052760 oxygen Inorganic materials 0.000 claims description 28
- 125000001424 substituent group Chemical group 0.000 claims description 28
- 229910052799 carbon Inorganic materials 0.000 claims description 26
- 125000000623 heterocyclic group Chemical group 0.000 claims description 25
- 125000001072 heteroaryl group Chemical group 0.000 claims description 24
- 125000005842 heteroatom Chemical group 0.000 claims description 23
- 150000001875 compounds Chemical class 0.000 claims description 20
- 125000004435 hydrogen atom Chemical group [H]* 0.000 claims description 16
- 125000006615 aromatic heterocyclic group Chemical group 0.000 claims description 13
- 125000005913 (C3-C6) cycloalkyl group Chemical group 0.000 claims description 12
- 150000003839 salts Chemical class 0.000 claims description 11
- 125000000217 alkyl group Chemical group 0.000 claims description 10
- -1 heterocyclyl-O— Chemical group 0.000 claims description 10
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical group [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 claims description 8
- 125000003831 tetrazolyl group Chemical group 0.000 claims description 8
- 125000002837 carbocyclic group Chemical group 0.000 claims description 6
- 125000000753 cycloalkyl group Chemical group 0.000 claims description 6
- 229910052739 hydrogen Inorganic materials 0.000 claims description 6
- 125000001624 naphthyl group Chemical group 0.000 claims description 6
- 229910052757 nitrogen Inorganic materials 0.000 claims description 6
- 125000004433 nitrogen atom Chemical group N* 0.000 claims description 6
- 125000000304 alkynyl group Chemical group 0.000 claims description 4
- 229920006395 saturated elastomer Polymers 0.000 claims description 4
- 125000006272 (C3-C7) cycloalkyl group Chemical group 0.000 claims description 3
- 239000008194 pharmaceutical composition Substances 0.000 claims description 3
- 102100033839 Glucose-dependent insulinotropic receptor Human genes 0.000 claims description 2
- 101000996752 Homo sapiens Glucose-dependent insulinotropic receptor Proteins 0.000 claims description 2
- 230000004913 activation Effects 0.000 claims description 2
- 201000010099 disease Diseases 0.000 claims description 2
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 claims description 2
- 125000001153 fluoro group Chemical group F* 0.000 claims description 2
- 230000001404 mediated effect Effects 0.000 claims description 2
- 238000000034 method Methods 0.000 description 4
- 239000003085 diluting agent Substances 0.000 description 2
- 239000000126 substance Substances 0.000 description 2
- UOKJXEROSWBCHJ-UHFFFAOYSA-N 3-fluoro-4-(tetrazol-1-yl)benzoic acid Chemical compound FC1=CC(C(=O)O)=CC=C1N1N=NN=C1 UOKJXEROSWBCHJ-UHFFFAOYSA-N 0.000 description 1
- 238000007792 addition Methods 0.000 description 1
- 239000000969 carrier Substances 0.000 description 1
- 238000001819 mass spectrum Methods 0.000 description 1
- 239000000203 mixture Substances 0.000 description 1
- 230000001225 therapeutic effect Effects 0.000 description 1
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP11158114.6 | 2011-03-14 | ||
| EP11158114 | 2011-03-14 | ||
| PCT/EP2012/054376 WO2012123449A1 (en) | 2011-03-14 | 2012-03-13 | N- cyclopropyl - n- piperidinylbenzamides as gpr119 modulators |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2014509600A JP2014509600A (ja) | 2014-04-21 |
| JP2014509600A5 true JP2014509600A5 (enExample) | 2015-04-30 |
| JP5935154B2 JP5935154B2 (ja) | 2016-06-15 |
Family
ID=45812800
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2013558409A Active JP5935154B2 (ja) | 2011-03-14 | 2012-03-13 | Ｇｐｒ１１９モジュレーターとしてのｎ−シクロプロピル−ｎ−ピペリジニルベンズアミド |
Country Status (4)
| Country | Link |
|---|---|
| US (1) | US8822471B2 (enExample) |
| EP (1) | EP2686312B1 (enExample) |
| JP (1) | JP5935154B2 (enExample) |
| WO (1) | WO2012123449A1 (enExample) |
Families Citing this family (15)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US8481731B2 (en) | 2009-06-24 | 2013-07-09 | Boehringer Ingelheim International Gmbh | Compounds, pharmaceutical composition and methods relating thereto |
| UY33805A (es) | 2010-12-17 | 2012-07-31 | Boehringer Ingelheim Int | ?Derivados de dihidrobenzofuranil-piperidinilo, aza-dihidrobenzofuranilpiperidinilo y diaza-dihidrobenzofuranil-piperidinilo, composiciones farmacéuticas que los contienen y usos de los mismos?. |
| WO2012123449A1 (en) | 2011-03-14 | 2012-09-20 | Boehringer Ingelheim International Gmbh | N- cyclopropyl - n- piperidinylbenzamides as gpr119 modulators |
| US8921398B2 (en) | 2011-06-09 | 2014-12-30 | Boehringer Ingelheim International Gmbh | N-cyclopropyl-N-piperidinyl-amide derivatives, pharmaceutical compositions and uses thereof |
| AU2013290100A1 (en) | 2012-07-11 | 2015-01-29 | Elcelyx Therapeutics, Inc. | Compositions comprising statins, biguanides and further agents for reducing cardiometabolic risk |
| JP2015523404A (ja) | 2012-08-02 | 2015-08-13 | ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング | Ｎ−シクロプロピル−ｎ−ピペリジニル−アミド、これらを含有する医薬組成物およびその使用 |
| ES2750640T3 (es) * | 2012-08-16 | 2020-03-26 | Scripps Research Inst | Ligandos opioides kappa novedosos |
| EP2892888B1 (en) * | 2012-09-10 | 2018-04-18 | Boehringer Ingelheim International GmbH | N-cyclopropyl-n-piperidinyl-amides, pharmaceutical compositions containing them, and uses thereof |
| WO2016138631A1 (en) * | 2015-03-03 | 2016-09-09 | Eli Lilly And Company | Imidazo benzamide compounds |
| EP3529245A4 (en) * | 2016-10-24 | 2020-12-23 | Yumanity Therapeutics, Inc. | COMPOUNDS AND USES OF THE LATEST |
| MA47212A (fr) | 2017-01-06 | 2019-11-13 | Yumanity Therapeutics Inc | Méthodes de traitement de troubles neurologiques |
| WO2019084157A1 (en) | 2017-10-24 | 2019-05-02 | Yumanity Therapeutics, Inc. | COMPOUNDS AND USES THEREOF |
| ES3043183T3 (en) | 2018-03-23 | 2025-11-25 | Janssen Pharmaceutica Nv | Compounds and uses thereof |
| MA54829A (fr) | 2019-01-24 | 2021-12-01 | Yumanity Therapeutics Inc | Composés et leurs utilisations |
| EA202192047A1 (ru) | 2019-11-13 | 2021-12-08 | Юманити Терапьютикс, Инк. | Соединения и их применение |
Family Cites Families (25)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| TWI326214B (en) * | 2002-07-17 | 2010-06-21 | Avanir Pharmaceuticals Inc | Pharmaceutical compositions comprising dextromethorphan and quinidine for the treatment of neurological disorders |
| US20060252797A1 (en) | 2002-11-06 | 2006-11-09 | Masahiro Kajino | Receptor regulator |
| US20070032475A1 (en) | 2005-04-15 | 2007-02-08 | Ye Xiaocong M | Novel compounds useful for bradykinin B1 receptor antagonism |
| US8039458B2 (en) | 2005-11-17 | 2011-10-18 | Bristol-Myers Squibb Company | HIV integrase inhibitors |
| TW200815377A (en) * | 2006-04-24 | 2008-04-01 | Astellas Pharma Inc | Oxadiazolidinedione compound |
| ATE476418T1 (de) * | 2006-06-08 | 2010-08-15 | Amgen Inc | Benzamidderivate und assoziierte verwendungen |
| DE102006035927A1 (de) * | 2006-07-31 | 2008-02-14 | Drei-S-Werk Präzisionswerkzeuge GmbH & Co Fertigungs-KG | Werkzeugsstift für eine Werkzeugform sowie Verfahren zum Herstellen eines solchen Werkzeugstifts |
| EP2059517A1 (en) | 2006-08-30 | 2009-05-20 | Biovitrum AB (publ) | Pyrimidine compounds for treating gpr119 related disorders |
| EP1903038A1 (de) * | 2006-09-07 | 2008-03-26 | Bayer Schering Pharma Aktiengesellschaft | N-(1-Hetaryl-piperidin-4-yl)-(het)arylamide als EP2-Rezeptor Modulatoren |
| DE602008002733D1 (de) * | 2007-03-08 | 2010-11-04 | Irm Llc | Verbindungen und zusammensetzungen als modulatoren der gpr119-aktivität |
| WO2008123992A1 (en) * | 2007-04-09 | 2008-10-16 | Tagnos, Inc. | Tag based knowledge system and methods for healthcare enterprises |
| PL2170864T3 (pl) * | 2007-07-17 | 2012-02-29 | Bristol Myers Squibb Co | Agoniści receptora gpr119 sprężonego z białkiem g - pirydon |
| WO2009129036A1 (en) * | 2008-04-14 | 2009-10-22 | Merck & Co., Inc. | Substituted cyclopropyl compounds, compositions containing such compounds and methods of treatment |
| BRPI0914891A2 (pt) * | 2008-06-20 | 2015-11-24 | Metabolex Inc | agonistas de aril gpr119 e usos dos mesmos |
| GB0812648D0 (en) * | 2008-07-10 | 2008-08-20 | Prosidion Ltd | Compounds |
| GB0812649D0 (en) * | 2008-07-10 | 2008-08-20 | Prosidion Ltd | Compounds |
| WO2010048149A2 (en) * | 2008-10-20 | 2010-04-29 | Kalypsys, Inc. | Heterocyclic modulators of gpr119 for treatment of disease |
| WO2010088518A2 (en) * | 2009-01-31 | 2010-08-05 | Kalypsys, Inc. | Heterocyclic modulators of gpr119 for treatment of disease |
| US8293729B2 (en) | 2009-06-24 | 2012-10-23 | Boehringer Ingelheim International Gmbh | Compounds, pharmaceutical composition and methods relating thereto |
| US8481731B2 (en) | 2009-06-24 | 2013-07-09 | Boehringer Ingelheim International Gmbh | Compounds, pharmaceutical composition and methods relating thereto |
| JP5794297B2 (ja) | 2010-05-07 | 2015-10-14 | ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング | Ｇｐｒ１１９アゴニストとしてのピリダジノン |
| UY33805A (es) | 2010-12-17 | 2012-07-31 | Boehringer Ingelheim Int | ?Derivados de dihidrobenzofuranil-piperidinilo, aza-dihidrobenzofuranilpiperidinilo y diaza-dihidrobenzofuranil-piperidinilo, composiciones farmacéuticas que los contienen y usos de los mismos?. |
| UY33871A (es) | 2011-01-21 | 2012-07-31 | Boehringer Ingelheim Int | Compuestos y formulaciones farmacéuticas basadas en derivados de benzo y heteroarilos condensados 2,3-dihidrofurán-2-il-piperidina y sus usos |
| WO2012123449A1 (en) | 2011-03-14 | 2012-09-20 | Boehringer Ingelheim International Gmbh | N- cyclopropyl - n- piperidinylbenzamides as gpr119 modulators |
| US8921398B2 (en) | 2011-06-09 | 2014-12-30 | Boehringer Ingelheim International Gmbh | N-cyclopropyl-N-piperidinyl-amide derivatives, pharmaceutical compositions and uses thereof |
-
2012
- 2012-03-13 WO PCT/EP2012/054376 patent/WO2012123449A1/en not_active Ceased
- 2012-03-13 EP EP12708044.8A patent/EP2686312B1/en active Active
- 2012-03-13 US US13/418,376 patent/US8822471B2/en active Active
- 2012-03-13 JP JP2013558409A patent/JP5935154B2/ja active Active
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2014516070A5 (enExample) | ||
| JP2014502988A5 (enExample) | ||
| JP2013545791A5 (enExample) | ||
| JP2017537882A5 (enExample) | ||
| NZ604074A (en) | Piperidinone derivatives as mdm2 inhibitors for the treatment of cancer | |
| JP2013531029A5 (enExample) | ||
| JP2012513416A5 (enExample) | ||
| JP2014525420A5 (enExample) | ||
| JP2016506958A5 (enExample) | ||
| EA027280B1 (ru) | Сульфамоил-ариламиды и их применение в качестве лекарственных препаратов для лечения гепатита b | |
| JP2013509392A5 (enExample) | ||
| JP2016530259A5 (enExample) | ||
| SI3018132T1 (en) | Condensed imidazole derivatives useful as IDO inhibitors | |
| RU2013143028A (ru) | Тиазолилфенилбензолсульфонамидопроизводные в качестве ингибиторов киназ | |
| JP2018502148A5 (enExample) | ||
| JP2014511892A5 (enExample) | ||
| RU2017144495A (ru) | Противогельминтные депсипептидные соединения | |
| JP2018527295A5 (enExample) | ||
| JP2011526917A5 (enExample) | ||
| RU2009143926A (ru) | Производные пиридина, замещенные гетероциклическим циклом и фосфоноаминогруппой, и содержащее их противогрибковое средство | |
| RU2014146995A (ru) | Сульфонамидное производное и его медицинское применение | |
| JP2014510147A5 (enExample) | ||
| JP2013063968A5 (enExample) | ||
| RU2011142154A (ru) | Производные фосфлокуназола, их синтез и применение в препаратах длительного действия | |
| JP2015500267A5 (enExample) |